Plasma Instead of Serum Avoids Critical Confounding of Clinical Metabolomics Studies by Platelets.

acetylsalicylic acid clinical metabolomics confounders drug effects lipid mediators metabolomics omega-3 fatty acids plasma platelets serum

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
23 Mar 2024
Historique:
medline: 23 3 2024
pubmed: 23 3 2024
entrez: 23 3 2024
Statut: aheadofprint

Résumé

Metabolomics is an emerging and powerful bioanalytical method supporting clinical investigations. Serum and plasma are commonly used without rational prioritization. Serum is collected after blood coagulation, a complex biochemical process involving active platelet metabolism. This may affect the metabolome and increase the variance, as platelet counts and function may vary substantially in individuals. A multiomics approach systematically investigating the suitability of serum and plasma for clinical studies demonstrated that metabolites correlated well (

Identifiants

pubmed: 38520676
doi: 10.1021/acs.jproteome.3c00761
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gerhard Hagn (G)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Vienna Doctoral School in Chemistry (DoSChem), University of Vienna, Waehringer Str. 42, 1090 Vienna, Austria.

Samuel M Meier-Menches (SM)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.

Günter Plessl-Walder (G)

Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.

Gaurav Mitra (G)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.

Thomas Mohr (T)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.

Karin Preindl (K)

Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Waehringer Gürtel 18-20, 1090 Vienna, Austria.

Andreas Schlatter (A)

Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.

Doreen Schmidl (D)

Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.

Christopher Gerner (C)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.

Gerhard Garhöfer (G)

Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.

Andrea Bileck (A)

Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria.
Joint Metabolome Facility, University and Medical University of Vienna, WaehringerStraße 38, 1090 Vienna, Austria.

Classifications MeSH